7Baggers
 Tango Therapeutics Flips To Profit And Banks Fresh Funding  Finimize Wed, 05 Nov 2025 17:19:11 GMT
 Tango Therapeutics Reports Promising Q3 2025 Results  TipRanks Wed, 05 Nov 2025 04:40:37 GMT
 tango therapeutics flips to profit and banks fresh funding  Finimize Tue, 04 Nov 2025 17:59:21 GMT
 Tango Therapeutics (TNGX) Q3 2025 Earnings: EPS of $0.14 Beats E  GuruFocus Tue, 04 Nov 2025 14:39:45 GMT
 tango therapeutic swings to profit in q3, revenue rises  MarketScreener Tue, 04 Nov 2025 14:28:12 GMT
 tango therapeutics, inc. sec 10-q report  TradingView Tue, 04 Nov 2025 14:13:01 GMT
 Tango Therapeutics reports Q3 net income, revenue jumps  TradingView Tue, 04 Nov 2025 14:07:35 GMT
 Tango Therapeutics reports Q3 EPS 14c, consensus (7c)  TipRanks Tue, 04 Nov 2025 08:00:00 GMT
 what is hc wainwright's estimate for tngx fy2026 earnings?  MarketBeat Fri, 31 Oct 2025 13:29:17 GMT
 tango’s first-in-class hbs1l/pelo degrader for focad-deleted cancers  BioWorld MedTech Fri, 31 Oct 2025 13:00:00 GMT
 tngx fy2025 eps forecast boosted by cantor fitzgerald  MarketBeat Thu, 30 Oct 2025 12:43:47 GMT
 tango therapeutics (tngx) upgraded to buy: here's why  sharewise.com Tue, 28 Oct 2025 07:39:41 GMT

Tango Therapeutics Inc
(NASDAQ:TNGX) 

TNGX stock logo

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine pho...

Sector: REAL ESTATE & CONSTRUCTION
Industry: BLANK CHECKS

Share this website to your friends